Today: 19 May 2026
Coherent stock drops as Bain affiliate flags another $2.2 billion sale — COHR share price in focus
10 February 2026
1 min read

Coherent stock drops as Bain affiliate flags another $2.2 billion sale — COHR share price in focus

New York, Feb 10, 2026, 14:07 (EST) — Regular session

  • Coherent shares dropped in the afternoon, following a stock sale filing from a Bain Capital affiliate.
  • The planned sale involves roughly 9.4 million shares, adding to a pair of sizable disposals from late last year.
  • Deal terms remain in focus for traders, with attention fixed on sponsor selling and its ongoing pressure on the stock.

Coherent Corp (COHR.N) slipped 4.4% to $231.70 Tuesday afternoon, as word got out that a major shareholder is looking to offload another chunk of shares. The photonics manufacturer’s stock swung between $225.38 and $240.50, with roughly 5.1 million shares traded by that point.

The filing is relevant right now: it signals more shares could hit the market in a name that’s already been running hot. Large secondary block sales, typically handled by banks and priced below market, have a tendency to knock a stock down, regardless of whether the underlying story shifts.

BCPE Watson (DE) BML, LP, a Bain Capital affiliate, moved to sell 9,437,238 shares in a fresh Form 144 filing, tallying up to roughly $2.22 billion, according to the document. Goldman Sachs & Co. LLC is on tap to manage the sale. Previous sales? The notice cites 5 million shares offloaded in December and another 7.5 million in November.

Form 144—a key notice under Rule 144—must be filed to signal a potential sale of restricted stock, as long as specific SEC conditions are met. The filing itself doesn’t confirm any shares have been sold yet, but it can hang over the stock, sometimes weighing on headlines.

Coherent produces engineered materials, lasers, and optoelectronic components, targeting customers in industrial, communications, and electronics sectors, among others. According to Reuters company data, its segments break down into Networking, Materials, and Lasers.

Investors are picking up on recent signals from management about demand. Chief Executive Jim Anderson, during last week’s quarterly update, pointed to “strong year-over-year revenue growth” and noted, “our non-GAAP earnings per share nearly doubled.” That figure refers to the company’s adjusted profit metric. GlobeNewswire

Anderson, speaking on the earnings call, told listeners that “the visibility of the business is the best it’s ever been.” That remark has been making the rounds among traders lately. The Motley Fool

The tape’s got a mind of its own—things can flip fast. Should the block require a steeper discount than traders bargained for, or if additional sponsor shares hit the market, any bounce might get capped by more selling.

Traders on Tuesday will keep an eye out for indications the proposed sale is progressing without hiccups, and they’ll be tracking any new filings that update ownership after the deals close.

Coherent will make an appearance at SEMICON Korea in Seoul from Feb. 11-13, joining a handful of upcoming industry events on investors’ radar for new signals on demand.

Stock Market Today

  • Wall Street Falls on Rising Oil Prices, Iran Concerns; Dow Drops 1.1%
    May 19, 2026, 6:07 AM EDT. Wall Street closed lower on May 18 as rising oil prices surged 3.4% to $109 a barrel and geopolitical tensions with Iran increased. The Dow Jones Industrial Average fell 1.1% to 49,526.17, led by a 4.4% drop in NVIDIA shares. The tech-heavy Nasdaq declined 1.5%, while the S&P 500 lost 1.2%. Defensive sectors like Energy rose as others, including Materials and Utilities, fell. The CBOE Volatility Index jumped 6.8%, signaling increased market fear. Industrial production surprised with a 0.7% April gain, and the NY Empire State Manufacturing Index surged to 19.6, pointing to robust manufacturing activity despite global tensions.

Latest articles

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.

Popular

Applied Digital’s AI Stock Just Hit a Wall After Its $7.5 Billion Win

Applied Digital’s AI Stock Just Hit a Wall After Its $7.5 Billion Win

18 May 2026
Applied Digital shares fell about 10% to $38.30 in midday trading Monday, retreating from an earlier high of $42.75 as investors took profits and re-evaluated risk in AI-infrastructure stocks. The drop followed a recent rally driven by a $7.5 billion, 15-year lease with a major U.S. cloud customer and the spin-off of its ChronoScale unit. Broader market declines and rising Treasury yields also weighed on the stock.
Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention
Previous Story

Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention

Abpro Holdings stock slides in premarket after Goldman stake filing sparks wild ABP swings
Next Story

Abpro Holdings stock slides in premarket after Goldman stake filing sparks wild ABP swings

Go toTop